Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
160.00B | 159.96B | 154.56B | 153.35B | 131.12B | 116.66B | Gross Profit |
27.17B | 25.30B | 26.66B | 26.32B | 23.91B | 20.64B | EBIT |
9.34B | 9.18B | 9.10B | 9.69B | 8.30B | 6.04B | EBITDA |
12.26B | 12.82B | 12.14B | 12.04B | 10.79B | 8.63B | Net Income Common Stockholders |
6.30B | 6.53B | 6.17B | 6.70B | 5.74B | 3.89B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.74B | 13.26B | 10.50B | 7.37B | 13.97B | 15.46B | Total Assets |
88.51B | 92.74B | 85.53B | 81.30B | 78.66B | 74.82B | Total Debt |
10.41B | 9.18B | 10.56B | 10.30B | 10.90B | 12.46B | Net Debt |
3.28B | -4.08B | 358.00M | 2.93B | -2.07B | -3.00B | Total Liabilities |
21.97B | 24.77B | 22.43B | 22.68B | 25.05B | 25.99B | Stockholders Equity |
66.54B | 67.97B | 63.11B | 58.62B | 53.61B | 48.83B |
Cash Flow | Free Cash Flow | ||||
0.00 | 5.89B | 4.67B | -3.51B | 1.40B | 8.05B | Operating Cash Flow |
0.00 | 7.33B | 7.72B | -1.21B | 3.62B | 11.03B | Investing Cash Flow |
0.00 | -849.00M | -2.88B | -1.62B | -3.19B | -3.00B | Financing Cash Flow |
0.00 | -3.42B | -2.00B | -2.77B | -2.93B | -2.51B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥36.09B | 5.68 | 7.76% | 3.49% | 4.57% | ||
76 Outperform | ¥9.11B | 11.58 | 2.82% | 11.34% | 22.75% | ||
76 Outperform | ¥28.24B | 7.08 | 5.05% | -4.95% | -39.29% | ||
70 Outperform | ¥127.01B | 17.13 | 2.01% | 24.35% | -35.21% | ||
65 Neutral | ¥55.84B | 10.75 | 5.09% | 12.85% | -22.91% | ||
62 Neutral | $6.82B | 11.05 | 2.80% | 4.32% | 2.67% | -24.92% | |
52 Neutral | ¥22.46B | 14.70 | 6.08% | 116.91% | -107.34% |